Safeway Launches Annual Companywide Breast Cancer Fundraising Campaign

Safeway, one of the largest corporate funding sources for cancer research, and its Safeway Foundation philanthropic arm, partnered with cancer scientists from government, the pharmaceutical industry, patient advocacy groups, and some of the most respected cancer centers in the country to address the major stumbling blocks that medical professionals say hinder the development of new breast cancer treatments: faster, more efficient clinical trials, and medicines that are designed to work better in individual patients.

"It is gratifying to see our fundraising dollars bear fruit," said Larree Renda, Safeway Executive Vice President, Chief Strategist and Administrative Officer and Chair of the Safeway Foundation. "We have teamed up with some of North America's premier cancer centers and we are beginning to see some encouraging results."

The first project, the I-SPY TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis) is managed by the Biomarkers Consortium in conjunction with the National Cancer Institute. The Consortium is a unique public-private partnership led by the Foundation for the National Institutes of Health that includes the Food and Drug Administration (FDA), the National Institutes of Health (NIH), and a large number of partners from major pharmaceutical companies, leading academic medical centers, non-profit and patient advocacy groups. Scientists from NCI, FDA, and major cancer research centers helped develop and will participate in the conduct of the trial. In the course of the trial, women with locally advanced breast cancer will be given promising drugs in development that are individually targeted to the biology of each woman's tumor. Researchers will use data from one set of patients' treatment to treat other patients, and thus more quickly eliminate ineffective treatments and drugs. In addition, the I-SPY trial will test the concept of personalized medicine by leveraging the molecular tools that have been developed over the last decade with the potential to identify and test new biomarkers as well.

The second Safeway Foundation-funded research initiative comes from the University of California, which is launching an unprecedented statewide collaboration for breast cancer patients with the goal of revolutionizing the course of their care by designing and testing new approaches to research, technology and health care delivery. The project, the ATHENA Breast Health Network, will initially involve 150,000 women throughout California who will be screened for breast cancer and followed for years to come through the five UC medical centers. The Safeway Foundation provided a $4.8 million grant, which will be coupled with a $5.3 million grant from the University of California.

The medical centers involved in this large-scale initiative are UC San Francisco who will serve as the host campus, UC Davis, UC Los Angeles, UC San Diego, and UC Irvine. Also participating in the collaboration are the UC Berkeley School of Public Health, the Northern California Cancer Center, Quantum Leap Healthcare Collaborative, the National Cancer Institute's BIG Health Consortium, and the Center for Medical Technology Policy.

Last year Safeway joined with UCSF to enable the nationwide launch of BreastCancerTrials.org, the nation's only online clinical trial matching service dedicated exclusively to breast cancer. Cancer patients, survivors and those who are at risk now have a free, easy-to-use resource that custom matches them to clinical trials specifically targeted to their personal health profiles. Using part of a $2 million grant from Safeway and The Safeway Foundation, the University of California at San Francisco's Carol Franc Buck Breast Care Center developed BreastCancerTrials.org which is now operated as a program of QuantumLeap Healthcare Collaborative, a non-profit corporation. BreastCancerTrials.org provides patient-friendly descriptions and information for over 160 trials now underway at more than 1,500 medical facilities across the country. During October, Safeway will publish messaging about BreastCancerTrials.org on its paper grocery bags and through brochures at the company's pharmacies to raise awareness of this important service.

Safeway has raised nearly $60 million for breast cancer research since 2001. During October, National Breast Cancer Awareness Month, the company will add significantly to that number through a range of additional fundraising programs at its local stores. The funds are donated to unique and promising research projects at various research facilities throughout North America, including:

-- Arizona: Mayo Clinic, Phoenix, The University of Arizona, Tucson

-- California: The Carol Franc Buck Breast Cancer Center at the University of California San Francisco, The University of California at Davis, Irvine and San Diego, The Revlon Women's Cancer Research Program at UCLA, University of Southern California

-- Canada: The Canadian Breast Cancer Foundation

-- Colorado: The Anschutz Breast Cancer Unit at the University of Colorado, The Susan G. Komen Foundation

-- Illinois: The Lurie Breast Cancer Unit at Northwestern University

-- Maryland: The Kimmel Cancer Center at Johns Hopkins University

-- Oregon: Providence Cancer Center

-- Pennsylvania: University of Pennsylvania

-- Texas: The Nellie B. Connally Breast Cancer Center at M.D. Anderson Cancer Center

-- Washington: The Fred Hutchinson Cancer Center

Cancer research is just one of the many important causes that the company supports each year. Safeway contributes to a broad range of charitable and community programs and in 2008 donated more than $248 million to education, hunger relief, health and human services and programs focused on assisting people with disabilities.

The company operates stores under the Safeway, Vons, Pavilions, Tom Thumb, Randalls, Dominick's, Genuardi's, Carrs and Pak 'N Save banners.

ABOUT SAFEWAY www.Safeway.com

Safeway Inc. is a Fortune 50 company and one of the largest food and drug retailers in North America, based on sales. The company operates 1,739 stores in the United States and western Canada and had annual sales of $44.1 billion in 2008. The company's common stock is traded on the New York Stock Exchange under the symbol SWY.

SOURCE: Safeway Inc.

Safeway Inc. 
Teena Massingill, 925-467-3810 
Teena.Massingill@Safeway.com